Study MK0767 and metformin in type 2 diabetic patients (0767-020)

Trial Profile

Study MK0767 and metformin in type 2 diabetic patients (0767-020)

Discontinued
Phase of Trial: Phase III

Latest Information Update: 15 Jul 2014

At a glance

  • Drugs Metformin; MK 0767
  • Indications Type 2 diabetes mellitus
  • Focus Registrational; Therapeutic Use
  • Sponsors Merck & Co; Merck Sharp & Dohme
  • Most Recent Events

    • 18 Feb 2014 According to the ClinicalTrials.gov record, status changed to discontinued.
    • 23 Oct 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top